clinical trial · NCT06693011
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Cerus Endovascular, Inc.·N/A·recruiting·n = 250
Cerebral AneurysmsContour Neurovascular System Treatment Attempt
brief summary
The goal of this clinical trial is to collect additional data to demonstrate if the Contour Neurovascular System (CNS) is a safe and effective treatment of wide-necked, saccular, intracranial aneurysms. Participants will: Undergo treatment with the Contour Neurovascular System Complete follow-up visits at 1month, 12months, and 24 months, following their procedure Report any adverse events to their study team
started
Jun 10, 2025
primary completion
Oct 1, 2028
completion
Jan 1, 2030
last updated
Mar 31, 2026
official title
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol